Does Type of Tumor Histology Impact Survival among Patients with Stage IIIB/IV Non-Small Cell Lung Cancer Treated with First-Line Doublet Chemotherapy?

<table>Flow of patients with Stage IIIB/IV who received cisplatin/carboplatin plus taxane (C/C+T) or cisplatin/carboplatin plus gemcitabine (C/C+G) first-line doublet chemotherapy from identification to sample selection.</table>

Chemotherapy Research and Practice

fig1

Figure 1

Figure 1: Does Type of Tumor Histology Impact Survival among Patients with Stage IIIB/IV Non-Small Cell Lung Cancer Treated with First-Line Doublet Chemotherapy? 

Figure 1 | Does Type of Tumor Histology Impact Survival among Patients with Stage IIIB/IV Non-Small Cell Lung Cancer Treated with First-Line Doublet Chemotherapy? 